Frankfurt - Delayed Quote • EUR Cytosorbents Corporation (HQE1.F) Follow Add holdings 0.7640 +0.0670 +(9.61%) At close: May 16 at 9:30:45 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for HQE1.F 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: HQE1.F View More All News Press Releases SEC Filings Q1 2025 Cytosorbents Corp Earnings Call CytoSorbents Corp (CTSO) Q1 2025 Earnings Call Highlights: Navigating Challenges and ... CytoSorbents: Q1 Earnings Snapshot CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update CTSO: CytoSorbents provides regulatory update for DrugSorb-ATR. CytoSorbents Provides Regulatory Update for DrugSorb-ATR CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants